Signant Health

Signant is the evidence generation company. Our SmartSignals suite combines software with deep scientific expertise to deliver high quality #clinicaltrial data

[Signant Health @SignantHealth]

Attend our #SCOPE2025 session "Practical Innovations with AI and Automation" to hear how we're transforming clinical research via AI-powered solutions. Schedule a meeting at booth #1013 to discover how cutting-edge approaches accelerate trial success.
https://t.co/uQkUozO2A9

[Signant Health @SignantHealth]

Subjective rating scales may challenge #immunology trials. The fix: electronic assessments with built-in standardization, specialized rater training, and real-time analytics. See this in a PsA trial: https://t.co/LtENYUEbAq
#ClinicalTrials

[Signant Health @SignantHealth]

At AAIC2025, our clinical science team will present data on screening optimization and endpoint reliability—two critical factors in successful Alzheimer’s disease trial design. Schedule time with our experts or get pre-conference resources: https://t.co/6RObpFqPfq

[Signant Health @SignantHealth]

Complex designs such as adaptive basket or umbrella trials are making RTSM builds more challenging. This blog covers best practices for implementation of adaptive trials: https://t.co/Bvk3nFNz06
#RTSM #ClinicalTrials #AdaptiveTrials

[Signant Health @SignantHealth]

Supply shortages derail study timelines and inflate budgets. Our Forecasting & Planning solution enables effective planning to prevent stockouts with real-time usage data and predictive modeling across your entire supply chain. 
Protect study timelines: https://t.co/o1ELVjr6iO

[Signant Health @SignantHealth]

Alzheimer’s trials are a maze. Let’s untangle the complexity together. Visit booth 1334 to talk with our team about optimal study design, reducing rater variability, ensuring eligibility, & building more signal-rich dementia trials. See details + posters:
https://t.co/9gVo7Nfu5F

[Signant Health @SignantHealth]

Signant's ops team has been recognized as a finalist for the OnCon Icon Top 100 Operations Team award. This recognition underscores our commitment to operational excellence as a catalyst for clinical research. Support innovation by voting for us: https://t.co/A49RWTamVs

[Signant Health @SignantHealth]

When choosing an eClinical partner, biotechs and emerging biopharma shouldn’t have to choose between working with an established, full-service company and a provider with a hands-on approach. Get the best of both worlds: https://t.co/KnJlLBprM4

[Signant Health @SignantHealth]

How can PRO data help inform optimal dose selection in early-phase #oncology #clinicaltrials? Our new guide makes the case for incorporating patient experience data for a more complete tolerability assessment. Get it here: https://t.co/7jnrYOQ3BP

[Signant Health @SignantHealth]

Running GLP-1 RA trials? Our ePRO handles the complexities – from dose escalation tracking and cardiovascular assessments to participant retention. Streamline your data capture and engagement strategy: https://t.co/5MJQb7Umn1

[Signant Health @SignantHealth]

Our new "Getting Started with eCOA" series is your go-to resource for mastering the essentials of electronic COAs. Explore our quick-read guides and get the insights you need to succeed. Check it out now: https://t.co/M6xyrkKQtm

#ClinicalTrials #eCOA #PatientCentricity

[Signant Health @SignantHealth]

The therapeutic promise of #psychedelic compounds is real, but so are the scientific challenges. Our latest blog reveals evidence-based strategies to maintain methodological rigor and study integrity in psychedelic #clinicaltrials: https://t.co/EgOw5yE5CU

[Signant Health @SignantHealth]

Early detection of cognitive effects can make or break your clinical program. Our CDR system's attention battery identifies cognitive changes in early-phase #clinicaltrials, helping you make confident decisions before costly failures https://t.co/84Pgi7lSvA

[Signant Health @SignantHealth]

🚀 Our TrialMax® platform features automation for the Data Change Form (DCF) process, reducing manual efforts, minimizing errors, and speeding up data management. Learn how TrialMax® is revolutionizing #eCOA study delivery: https://t.co/OGPhaJXNh6

[Signant Health @SignantHealth]

How might placebo response and expectation bias impact #clinicaltrial outcomes? How can they be mitigated to ensure data reliability? Get answers from experts here:
https://t.co/NlXQaclePj

[Signant Health @SignantHealth]

Pediatric depression #clinicaltrials have challenges: limited sites, variable CDRS-R administration, and complex multi-stakeholder interviews. See how our CDRS-R solution addresses them: https://t.co/saTzjhOBgE
#pediatricdepression

[Signant Health @SignantHealth]

Accelerate your vaccine research with trial-tested eCOA, RTSM, eConsent, telemedicine, and patient Engagement solutions. With experience in 200+ studies across 30+ countries, we're ready to help bring your vaccine to the public quickly and efficiently. https://t.co/7ebXaFr9ge

[Signant Health @SignantHealth]

Leading technology without limits: Global pharmaceutical leaders rely on our comprehensive #eCOA, eClinRO, and #RTSM solutions for reliable evidence generation. No surprises, just flexible tech backed by expert teams. Explore industry-standard solutions: https://t.co/BqbLp9jmP0

[Signant Health @SignantHealth]

Sites using too many systems? Our EDC offers add-on modules for eCOA, eConsent, and Randomization. One platform, one login, and happy sites. Take a look:
https://t.co/QkiD0ZR5kI

[Signant Health @SignantHealth]

The placebo effect is a contributing factor in the low success rates of novel pain medication #clinicaltrials, where less than 5% of low-abuse potential drugs gain approval. See how we helped one pharma company limit placebo effect and gain FDA approval: https://t.co/O4O4f4hmZi

[Signant Health @SignantHealth]

With our novel patient-reported outcome measure, PROMIS CAT, study teams can capture precise data from fewer questions or items, reducing completion burden for patients. Bonus: Incorporate it alongside traditional COAs. Get details: https://t.co/KiYCiF6acZ